Leveraging Type I Interferons: Exploring Pathogenesis and Therapeutic Strategies in Autoimmune Diseases.

Jabbari S, Safaralizadeh R, Beilankouhi EAV, Valilo M, Hosseinpourfeizi M, Baradaran B, Khodavirdipour A, Hemmat N

Open source

DOI
10.1615/critrevimmunol.2026062673
Published
2026
Container
Critical reviews in immunology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1615/critrevimmunol.2026062673,
  title = {Leveraging Type I Interferons: Exploring Pathogenesis and Therapeutic Strategies in Autoimmune Diseases.},
  author = {Jabbari S and Safaralizadeh R and Beilankouhi EAV and Valilo M and Hosseinpourfeizi M and Baradaran B and Khodavirdipour A and Hemmat N},
  year = {2026},
  journal = {Critical reviews in immunology},
  doi = {10.1615/critrevimmunol.2026062673},
  url = {https://doi.org/10.1615/critrevimmunol.2026062673}
}

RIS

TY  - JOUR
TI  - Leveraging Type I Interferons: Exploring Pathogenesis and Therapeutic Strategies in Autoimmune Diseases.
AU  - Jabbari S
AU  - Safaralizadeh R
AU  - Beilankouhi EAV
AU  - Valilo M
AU  - Hosseinpourfeizi M
AU  - Baradaran B
AU  - Khodavirdipour A
AU  - Hemmat N
PY  - 2026
JO  - Critical reviews in immunology
DO  - 10.1615/critrevimmunol.2026062673
UR  - https://doi.org/10.1615/critrevimmunol.2026062673
ER  - 

APA

S, J., R, S., EAV, B., M, V., M, H., B, B., A, K., & N, H. (2026). Leveraging Type I Interferons: Exploring Pathogenesis and Therapeutic Strategies in Autoimmune Diseases.. Critical reviews in immunology. https://doi.org/10.1615/critrevimmunol.2026062673

Source records